Systemic lupus erythematosus--immunoregulatory therapies.
D000818:Animals; D001379:Azathioprine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000627:therapeutic use; D004195:Disease Models, Animal; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage; D051379:Mice; D008814:Mice, Inbred NZB; D008815:Mice, Inbred Strains; D009393:Nephritis / Q000188:drug therapy*; D010956:Plasmapheresis; D011897:Random Allocation
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D001379:Azathioprine; D008775:Methylprednisolone